Nathaniel B. Langer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nathaniel B. Langer has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Asishana Avo Osho
Massachusetts General Hospital, Harvard Medical School
4 shared publications - Sammy Elmariah
Division of Cardiology, University of California-San Francisco, San Francisco, California, USA
3 shared publications - Silvana Crowley Carrasco
Thoracic Surgery and Lung Transplantation Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
3 shared publications - Amir Emtiazjoo
Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, FL
2 shared publications - Andrés Leon-Peña
Division of Cardiopulmonary Transplantation and Mechanical Circulatory Support, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
2 shared publications Arminder S. Jassar
Harvard Medical School
2 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Elsevier in American Journal of Transplantation
Real-world evaluation of recombinant zoster vaccine uptake and outcomes in solid organ transplant recipients: A retrospective cohort study
- 28 September 2026
- Published by Elsevier in American Journal of Transplantation
Open AccessReal-world evaluation of recombinant zoster vaccine uptake and outcomes in solid organ transplant recipients: A retrospective cohort study
- Open Access
- 16 May 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (9) , 1522-1525
The need for clarity among the shadows: It is time to further refine the definition of primary graft dysfunction in lung transplant recipients
- 16 May 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (9) , 1522-1525
Open AccessThe need for clarity among the shadows: It is time to further refine the definition of primary graft dysfunction in lung transplant recipients
- Open Access
- 7 April 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (7) , e045002
Sex‐Based Differences in Outcomes Following Mitral Valve Surgery: A Contemporary Analysis From 2 Institutions
Background: Despite differences in operative characteristics in patients with mitral valve disease, it remains unclear if sex is an independent risk factor associated with perioperative mortality after mitral valve surgery. Methods: We performed a retrospective cohort study of 3313 adult patients who underwent mitral valve surgery between 2011 and 2024 at 2 academic institutions. Patients were stratified by sex, and the primary outcome was operative mortality. Multivariable logistic regression was used to identify independent predictors of operative mortality. Results: In our cohort, 44.5% were women. Women were older (63.9 versus 62.2 years, P P P P P P =0.32). In multivariable regression, female sex was not significantly associated with mortality after adjusting for covariates (odds ratio [OR], 1.03 [95% CI, 0.39–2.77], P =0.66). Prolonged cardiopulmonary bypass time was significantly associated with an increased odds of postoperative mortality (OR, 1.01 per 10 minutes [95% CI, 1.01–1.02], P =0.002). Conclusions: Despite differences in baseline characteristics and surgical approach, operative mortality did not differ significantly by sex. Female sex was not significantly associated with operative mortality after adjustment for clinical and operative factors in patients undergoing elective mitral valve surgery.
- 7 April 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (7) , e045002
Open AccessSex‐Based Differences in Outcomes Following Mitral Valve Surgery: A Contemporary Analysis From 2 Institutions
Background: Despite differences in operative characteristics in patients with mitral valve disease, it remains unclear if sex is an independent risk factor associated with perioperative mortality after mitral valve surgery. Methods: We performed a retrospective cohort study of 3313 adult patients who underwent mitral valve surgery between 2011 and 2024 at 2 academic institutions. Patients were stratified by sex, and the primary outcome was operative mortality. Multivariable logistic regression was used to identify independent predictors of operative mortality. Results: In our cohort, 44.5% were women. Women were older (63.9 versus 62.2 years, P P P P P P =0.32). In multivariable regression, female sex was not significantly associated with mortality after adjusting for covariates (odds ratio [OR], 1.03 [95% CI, 0.39–2.77], P =0.66). Prolonged cardiopulmonary bypass time was significantly associated with an increased odds of postoperative mortality (OR, 1.01 per 10 minutes [95% CI, 1.01–1.02], P =0.002). Conclusions: Despite differences in baseline characteristics and surgical approach, operative mortality did not differ significantly by sex. Female sex was not significantly associated with operative mortality after adjustment for clinical and operative factors in patients undergoing elective mitral valve surgery.
- Open Access
- 9 October 2025
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (2) , 242-250
Outcomes of central versus peripheral arterial cannulation for intraoperative extracorporeal membrane oxygenation support in lung transplantation
- 9 October 2025
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (2) , 242-250
Open AccessOutcomes of central versus peripheral arterial cannulation for intraoperative extracorporeal membrane oxygenation support in lung transplantation
- Top Cited Papers
- 27 May 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (21) , 1498-1507
Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial
BACKGROUND: Symptomatic severe aortic stenosis (AS) remains undertreated with high resultant mortality despite increased growth and availability of aortic valve replacement (AVR) since the advent of transcatheter therapies. We evaluate the impact of electronic provider notifications (EPNs) on rates of AVR at 1 year. METHODS: In a pragmatic cluster randomized clinical trial conducted within a multicenter academic health system from March 2022 through November 2023, 285 providers who had ordered a transthoracic echocardiogram (TTE) with findings potentially indicative of severe AS with an aortic valve area ≤1.0 cm 2 were enrolled. Providers were randomly assigned to receive EPNs for each of their patients with severe AS on TTE or to usual care. Notifications highlighted the detection of severe AS and included patient-specific clinical guideline recommendations for its management. The primary end point was the proportion of patients with severe AS receiving AVR within 1 year of the index TTE. RESULTS: A total of 144 providers were randomized to intervention and 141 to control, resulting in 496 and 443 patients assigned to each group, respectively. The patient cohort had mean age of 77±11 years, was 47% female, and had a mean aortic valve area of 0.8±0.1 cm 2 . Rates of AVR within 1 year were 48.2% with EPNs versus 37.2% with usual care (odds ratio [OR], 1.62 [95% CI, 1.13–2.32]; P =0.009]) and 60.7% and 46.5%, respectively, among symptomatic patients (OR, 1.77 [95% CI, 1.17–2.65]; P =0.006). Notification treatment effect was highest with EPNs for patients >80 years of age (OR, 2.00 [95% CI, 1.17–3.41]; P =0.01), for women (OR, 2.78, [95% CI, 1.69–4.57]; P P P =0.04) and symptomatic patients (23 days; P =0.01). CONCLUSIONS: In this first study of EPNs for valvular heart disease, EPNs increased rates of AVR for severe AS, lessened sex and age disparities in AVR use, and improved survival time. EPNs may be a simple, scalable intervention to raise awareness of critical TTE findings and improve the quality of care for patients with severe AS. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05230225.
- 27 May 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (21) , 1498-1507
Top Cited PapersElectronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial
BACKGROUND: Symptomatic severe aortic stenosis (AS) remains undertreated with high resultant mortality despite increased growth and availability of aortic valve replacement (AVR) since the advent of transcatheter therapies. We evaluate the impact of electronic provider notifications (EPNs) on rates of AVR at 1 year. METHODS: In a pragmatic cluster randomized clinical trial conducted within a multicenter academic health system from March 2022 through November 2023, 285 providers who had ordered a transthoracic echocardiogram (TTE) with findings potentially indicative of severe AS with an aortic valve area ≤1.0 cm 2 were enrolled. Providers were randomly assigned to receive EPNs for each of their patients with severe AS on TTE or to usual care. Notifications highlighted the detection of severe AS and included patient-specific clinical guideline recommendations for its management. The primary end point was the proportion of patients with severe AS receiving AVR within 1 year of the index TTE. RESULTS: A total of 144 providers were randomized to intervention and 141 to control, resulting in 496 and 443 patients assigned to each group, respectively. The patient cohort had mean age of 77±11 years, was 47% female, and had a mean aortic valve area of 0.8±0.1 cm 2 . Rates of AVR within 1 year were 48.2% with EPNs versus 37.2% with usual care (odds ratio [OR], 1.62 [95% CI, 1.13–2.32]; P =0.009]) and 60.7% and 46.5%, respectively, among symptomatic patients (OR, 1.77 [95% CI, 1.17–2.65]; P =0.006). Notification treatment effect was highest with EPNs for patients >80 years of age (OR, 2.00 [95% CI, 1.17–3.41]; P =0.01), for women (OR, 2.78, [95% CI, 1.69–4.57]; P P P =0.04) and symptomatic patients (23 days; P =0.01). CONCLUSIONS: In this first study of EPNs for valvular heart disease, EPNs increased rates of AVR for severe AS, lessened sex and age disparities in AVR use, and improved survival time. EPNs may be a simple, scalable intervention to raise awareness of critical TTE findings and improve the quality of care for patients with severe AS. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05230225.
- Open Access
- 4 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (5) , e038464
BIO4LIFE—Surgical Aortic Valve Replacement Followed by Valve‐in‐Valve Transcatheter Aortic Valve Replacement for Lifetime Management of Aortic Valve Disease: Panacea or Fairytale?
- 4 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (5) , e038464
Open AccessBIO4LIFE—Surgical Aortic Valve Replacement Followed by Valve‐in‐Valve Transcatheter Aortic Valve Replacement for Lifetime Management of Aortic Valve Disease: Panacea or Fairytale?
- 28 October 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 119 (2) , 431-432
Is It Time for Lung Transplantation to Step Fully Into the Light?
- 28 October 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 119 (2) , 431-432
Is It Time for Lung Transplantation to Step Fully Into the Light?
- 28 May 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 118 (2) , 504-505
A Bridge Over Troubled Waters: Insights Into Extracorporeal Membrane Oxygenation Bridge-to-Transplant Outcomes From the Organ Procurement and Transplantation Network Standard Transplant Analysis and Research Database
- 28 May 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 118 (2) , 504-505
A Bridge Over Troubled Waters: Insights Into Extracorporeal Membrane Oxygenation Bridge-to-Transplant Outcomes From the Organ Procurement and Transplantation Network Standard Transplant Analysis and Research Database
- 25 January 2024
- Published by Springer Nature
- p. 275-282
Acute and Chronic Pulmonary Embolism